Rilmenidine phosphate ydroabietic acid ” between switch I and

” between switch I and II on RAS

FDA approved T rametinib

CC-90011 (Compound 11

6-diaminohexanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid

Rilmenidine phosphate ydroabietic acid ” between switch I andRilmenidine phosphate, an innovative antihypertensive agent, is an orally active, selective I1 imidazoline receptor agonist. Rilmenidine phosphate is an alpha 2 adrenoceptor agonist. Rilmenidine phosphate induces autophagy. Rilmenidine phosphate acts both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+ H+ antiport. Rilmenidine phosphate modulates proliferation and stimulates the proapoptotic protein Bax thus